* Personalis Inc PSNL.OQ reported a quarterly adjusted
loss
of 26 cents per share for the quarter ended in January, higher
than the same quarter last year, when the company reported EPS
of -61 cents. The mean expectation of six analysts for the
quarter was for a loss of 41 cents per share. Wall Street
expected results to range from -52 cents to -36 cents per share.
* Revenue rose 3.5% to $19.53 million from a year ago;
analysts
expected $18.36 million.
* Personalis Inc's reported EPS for the quarter was a loss
of 26
cents.
* The company reported a quarterly loss of $12.97 million.
* Personalis Inc shares had risen by 5.0% this quarter and
lost 25.5% so far this year.
FORECAST CHANGES
* The mean earnings estimate of analysts had risen by
about 16.3%
in the last three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."
* The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"
Wall Street's median 12-month price target for Personalis Inc is
$4.00
This summary was machine generated from LSEG data May 9 at 10:14
a.m. UTC. All figures in US dollars unless otherwise stated.
(For questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Mar. 31 2024 -0.41 -0.26 Beat
Dec. 31 2023 -0.50 -0.54 Missed
Sep. 30 2023 -0.53 -0.48 Beat
Jun. 30 2023 -0.53 -0.50 Beat